These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24612301)

  • 41. Depression and antidepressant treatment in the development of hypertensive disorders of pregnancy: Results from a prospective cohort study.
    Galbally M; Watson SJ; Spigset O
    Aust N Z J Psychiatry; 2023 Apr; 57(4):520-527. PubMed ID: 35786007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between antidepressant medication use and rate of suicide.
    Gibbons RD; Hur K; Bhaumik DK; Mann JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):165-72. PubMed ID: 15699293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies.
    Wang S; Yang L; Wang L; Gao L; Xu B; Xiong Y
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25991012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
    Schlienger RG; Fischer LM; Jick H; Meier CR
    Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.
    Yazdy MM; Mitchell AA; Louik C; Werler MM
    Epidemiology; 2014 Nov; 25(6):859-65. PubMed ID: 25171134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses.
    Nijenhuis CM; ter Horst PG; van Rein N; Wilffert B; de Jong-van den Berg LT
    Br J Clin Pharmacol; 2012 Jan; 73(1):126-34. PubMed ID: 21848990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between antidepressant use during pregnancy and congenital anomalies in children: A retrospective cohort study based on Japanese claims data.
    Yamamoto-Sasaki M; Yoshida S; Takeuchi M; Tanaka-Mizuno S; Kawakami K
    Congenit Anom (Kyoto); 2020 Nov; 60(6):180-188. PubMed ID: 32673440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
    Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
    PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and predictors of tricyclic antidepressant use among elderly Koreans in primary-care and specialty clinics.
    Hwang JE; Song I; Lee EK; Ha D; Shin JY
    Int J Clin Pharmacol Ther; 2018 May; 56(5):224-230. PubMed ID: 29578393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
    Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
    Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antidepressant use and risk for preeclampsia.
    Palmsten K; Huybrechts KF; Michels KB; Williams PL; Mogun H; Setoguchi S; Hernández-Díaz S
    Epidemiology; 2013 Sep; 24(5):682-91. PubMed ID: 23873072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
    Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
    N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
    Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
    JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children.
    ter Horst PG; Bos HJ; de Jong-van de Berg LT; Wilffert B
    Eur J Clin Pharmacol; 2013 Mar; 69(3):541-7. PubMed ID: 22815049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
    Kulin NA; Pastuszak A; Sage SR; Schick-Boschetto B; Spivey G; Feldkamp M; Ormond K; Matsui D; Stein-Schechman AK; Cook L; Brochu J; Rieder M; Koren G
    JAMA; 1998 Feb; 279(8):609-10. PubMed ID: 9486756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.